Schroder Investment Management Group’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-124,252
| Closed | -$2.38M | – | 1323 |
|
|
2017
Q1 | $2.38M | Buy |
124,252
+13,510
| +12% | +$258K | ﹤0.01% | 816 |
|
|
2016
Q4 | $1.85M | Sell |
110,742
-3,530
| -3% | -$58.8K | ﹤0.01% | 835 |
|
|
2016
Q3 | $2.35M | Buy |
114,272
+89,626
| +364% | +$1.84M | ﹤0.01% | 819 |
|
|
2016
Q2 | $754K | Sell |
24,646
-9,062
| -27% | -$277K | ﹤0.01% | 940 |
|
|
2016
Q1 | $1.26M | Buy |
+33,708
| New | +$1.26M | ﹤0.01% | 889 |
|
|
2015
Q1 | – | Sell |
-14,056
| Closed | -$479K | – | 1287 |
|
|
2014
Q4 | $479K | Sell |
14,056
-2,120,080
| -99% | -$72.2M | ﹤0.01% | 1072 |
|
|
2014
Q3 | $82.3M | Buy |
2,134,136
+294,705
| +16% | +$11.4M | 0.11% | 177 |
|
|
2014
Q2 | $71.6M | Buy |
1,839,431
+170,500
| +10% | +$6.64M | 0.09% | 202 |
|
|
2014
Q1 | $57.1M | Sell |
1,668,931
-235,119
| -12% | -$8.04M | 0.06% | 243 |
|
|
2013
Q4 | $39.9M | Buy |
1,904,050
+1,535,300
| +416% | +$32.2M | 0.05% | 302 |
|
|
2013
Q3 | $8.67M | Buy |
368,750
+166,350
| +82% | +$3.91M | 0.02% | 661 |
|
|
2013
Q2 | $5.44M | Buy |
+202,400
| New | +$5.44M | 0.01% | 735 |
|